ADReCS: An ontology database for aiding standardization and hierarchical Classification of adverse drug reaction terms

Nucleic Acids Research

Volumn 43, Issue D1, 2015, Pages D907-D913

  Cai, Mei Chun ^a   Xu, Quan ^a   Pan, Yan Jing ^a   Pan, Wen ^a   Ji, Nan ^b   Li, Yin Bo ^a   Liu, Hai Jing Jin Ke ^a   Ji, Zhi Liang ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ADRECS DATABASE; ADVERSE DRUG REACTION; ARTICLE; BIOINFORMATICS; DATA BASE; INFORMATION RETRIEVAL; MEDICAL SUBJECT HEADINGS; MOLECULAR MECHANICS; ONTOLOGY; PRIORITY JOURNAL; RISK REDUCTION; STANDARDIZATION; BIOLOGICAL ONTOLOGY; CLASSIFICATION; FACTUAL DATABASE; INTERNET; NOMENCLATURE; PROCEDURES;

BIOLOGICAL ONTOLOGIES; CLASSIFICATION; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; INTERNET; TERMINOLOGY AS TOPIC;

EID: 84944725194     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1066     Document Type: Article

References (19)

1. WHO. (2002) Safety of Medicines: A guide to detecting and reporting adverse drug reactions. World Health Organization, WHO/EDM/QSM/2002.2.
2. Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R. and Nakamura, Y. (2007) When good drugs go bad. Nature, 446, 975-977.
3. Kavitha, D. (2010) Adverse drug reaction (ADR) monitoring and pharmacovigilance. Asian J. Pharm. Res. Health Care, 2, 127-134.
4. Arrowsmith, J. and Miller, P. (2013) Trial watch: phase II and phase III attrition rates 2011-2012. Nat. Rev. Drug Discov., 12, 569.
5. Paludetto, M. N., Olivier-Abbal, P. and Montastruc, J. L. (2012) Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? Pharmacoepidemiol. Drug Saf., 21, 1289-1294.
6. Clarke, A., Deeks, J. J. and Shakir, S. A. (2006) An assessment of the publicly disseminated evidence of safety used in decisions to withdraw medicinal products from the UK and US markets. Drug Saf., 29, 175-181.
7. Brown, E. G., Wood, L. and Wood, S. (1999) The medical dictionary for regulatory activities (MedDRA). Drug Saf., 20, 109-117.
8. Waters, M. D. and Fostel, J. M. (2004) Toxicogenomics and systems toxicology: aims and prospects. Nat. Rev. Genet., 5, 936-948.
9. Berger, S. I. and Iyengar, R. (2011) Role of systems pharmacology in understanding drug adverse events. Wiley Interdiscip. Rev. Syst. Biol. Med., 3, 129-135.
10. Zhichkin, P. E., Athey, B. D., Avigan, M. I. and Abernethy, D. R. (2012) Needs for an expanded ontology-based classification of adverse drug reactions and related mechanisms. Clin. Pharmacol. Ther., 91, 963-965.
11. Bousquet, C., Sadou, E., Souvignet, J., Jaulent, M. C. and Declerck, G. (2014) Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms. J. Biomed. Inform., 49, 282-291.
12. Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J. and Bork, P. (2010) A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol., 6, 343.
13. Bodenreider, O. (2004) The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res., 32, D267-D270.
14. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V. et al. (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res., 42, D1091-D1097.
15. Wang, Y., Suzek, T., Zhang, J., Wang, J., He, S., Cheng, T., Shoemaker, B. A., Gindulyte, A. and Bryant, S. H. (2014) PubChem BioAssay: 2014 update. Nucleic Acids Res., 42, D1075-D1082.
16. Kanehisa, M., Goto, S., Sato, Y., Kawashima, M., Furumichi, M. and Tanabe, M. (2014) Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res., 42, D199-D205.
17. Richesson, R. L., Fung, K. W. and Krischer, J. P. (2008) Heterogeneous but "standard" coding systems for adverse events: issues in achieving interoperability between apples and oranges. Contemp. Clin. Trials, 29, 635-645.
18. Liu, M., Wu, Y., Chen, Y., Sun, J., Zhao, Z., Chen, X. W., Matheny, M. E. and Xu, H. (2012) Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J. Am. Med. Inform. Assoc., 19, e28-e35.
19. Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Cote, S. et al. (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature, 486, 361-367.